✦ LIBER ✦

Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT)

✍ Scribed by The European Nicotinamide Diabetes Intervention Trial (ENDIT) Group*

Publisher: Springer
Year: 2003
Tongue: English
Weight: 80 KB
Volume: 46
Category: Article
ISSN: 0012-186X
DOI: 10.1007/s00125-003-1202-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progression to type 1 diabetes in islet

Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk

✍ The European Nicotinamide Diabetes Intervention Trial (ENDIT) Group; P. J. Bingl 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 170 KB

A multi-centre randomized trial of two d

A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset Type 1 diabetes (the IMDIAB VI)

✍ Natalia Visalli; Maria G. Cavallo; Alberto Signore; Marco G. Baroni; Raffaella B 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

Background Intensive insulin therapy is the gold standard by which Type 1 diabetes is treated. In addition to this therapy, administration of nicotinamide (NA) can be bene®cial. This concept is reinforced by the results of a recent meta-analysis of the use of NA in patients with recent-onset Type 1

Long-term detrimental consequences of th

Long-term detrimental consequences of the onset of type 1 diabetes on annual earnings—evidence from annual registry data in 1990–2005

✍ K. Steen Carlsson; M. Landin-Olsson; L. Nyström; H. J. Arnqvist; J. Bolinder; J. 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 208 KB